DOI QR코드

DOI QR Code

Short-term Mechanical Circulatory Support with a Centrifugal Pump - Results of Peripheral Extracorporeal Membrane Oxygenator According to Clinical Situation

  • Lee, Woo-Surng (Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University) ;
  • Chee, Hyun-Keun (Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University) ;
  • Song, Meong-Gun (Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University) ;
  • Kim, Yo-Han (Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University) ;
  • Shin, Je-Kyoun (Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University) ;
  • Kim, Jun-Seok (Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University) ;
  • Lee, Song-Am (Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University) ;
  • Hwang, Jae-Joon (Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University)
  • Received : 2010.07.23
  • Accepted : 2011.01.20
  • Published : 2011.02.05

Abstract

Background: A peripheral extracorporeal membrane oxygenator (p-ECMO) has been developed to support patients who are dying due to a serious cardiopulmonary condition. This analysis was planned to define the clinical situation in which the patient benefits most from a p-ECMO. Material and Methods: Between June 2007 and Aug 2009, a total of 41 adult patients used the p-ECMO. There were 23 males and 18 females (mean age $54.4{\pm}15.1$ years). All patients had very unstable vital signs with hypoxia and complex cardiac problems. We divided the patients into 4 groups. In the first group, a p-ECMO was used as a bridge to cardiac operation. In the second group, patients did not have the opportunity to undergo any cardiac procedures; nevertheless, they were treated with a p-ECMO. In the third group, patients mostly had difficulty in weaning from CPB (cardiopulmonary bypass) after cardiac operation. The fourth group suffered from many complications, such as pneumonia, bleeding, infections, and LV dysfunction with underlying cardiac problems. All cannulations were performed by the Seldinger technique or cutting down the femoral vessel. A long venous cannula of $DLP^{(R)}$ (Medtronic Inc, Minneapolis, MN) or $RMI^{(R)}$ (Edwards Lifesciences LLC, Irvine, CA) was used together with a 17~21 Fr arterial cannula and a 21 Fr venous cannula. As a bypass pump, a Capiox emergency bypass system ($EBS^{(R)}$; Terumo, Tokyo, Japan) was used. We attempted to maintain a flow rate of $2.4{\sim}3.0\;L/min/m^2$ and an activated clotting time (ACT) of around 180 seconds. Results: Nine patients survived by the use of the p-ECMO. Ten patients were weaned from a p-ECMO but they did not survive, and the remainder had no chance to be weaned from the p-ECMO. The best clinical situation to apply the p-ECMO was to use it as a bridge to cardiac operation and for weaning from CPB after cardiac operation. Conclusion: Various clinical results were derived by p-ECMO according to the clinical situation. For the best results, early adoption of the p-ECMO for anatomical correction appears important.

Keywords

Acknowledgement

Supported by : Konkuk University Medical Center

References

  1. Reardon MJ, Conklin LD, Letsou GV, Safi HJ, Espada R, Baldwin JC. Methods of acute postcardiotomy left ventricular assistance. J Cardiovasc Surg 1999;40:627-31.
  2. Magovern GJ, Simpson KA. Extracorporeal membrane oxy-genation for adult cardiac support: the allegheny experience. Ann Thorac Surg 1999;68:655-61. https://doi.org/10.1016/S0003-4975(99)00581-0
  3. Sung K, Lee YT, Park PW, et al. Improved survival after cardiac arrest using emergent autopriming percutaneous cardiopulmonary support. Ann Thorac Surg 2006;82:651-6. https://doi.org/10.1016/j.athoracsur.2006.03.017
  4. Chen YS, Lin JW, Yu HY, et al. Cardiopulmonary resuscitation with assisted extracorporeal life support versus conventional cardiopulmonary resuscitation in adults with inhospital cardiac arrest: an observational study and propensity analysis. Lancet 2008;372:554-61. https://doi.org/10.1016/S0140-6736(08)60958-7
  5. Schwarz B, Mair P, Margreiter J, et al. Experience with percutaneous venoarterial cardiopulmonary bypass for emergency circulatory support. Crit Care Med 2003;31:758-64. https://doi.org/10.1097/01.CCM.0000053522.55711.E3
  6. Bartlett RH, Gazzaniga AB, Jefferies MR, et al. Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infants. ASAIO Trans 1976;22:80-93.
  7. Wu MY, Lin PJ, Tsai FC, Haung YK, Liu KS, Tsai FC. Impact of preexisting organ dysfunction on extracorporeal life support for non-postcardiotomy cardiopulmonary failure. Resuscitation 2008;79:54-60. https://doi.org/10.1016/j.resuscitation.2008.05.002
  8. Bakhtiary F, Keller H, Dogan S, et al. Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: Clinical experiences in 45 adult patients. J Thorac Cardiovasc Surg 2008;135:382-8. https://doi.org/10.1016/j.jtcvs.2007.08.007
  9. Formica F, Avalli L, Martino A, et al. Extracorporeal membrane oxygenation with a poly-methylpentene oxygenator (Quadrox D). The experience of a single italian centre in adult patients with refractory cardiogenic shock. ASAIO J 2008;54:89-94. https://doi.org/10.1097/MAT.0b013e31815ff27e
  10. Reedy JE, Swartz MT, Raithel SC, et al. Mechanical cardiopulmonary support for refractory cardiogenic shock. Heart Lung 1990;19:514-23.
  11. Shawl FA, Domanski MJ, Punja A, Hemandez T. Emergency percutaneous cardiopulmonary bypass support in cardiopulmonary shock from acute myocardial infarction. Am J Cardiol 1989;64:967-70. https://doi.org/10.1016/0002-9149(89)90791-1
  12. Reichman RT, Joyo CI, Dembisky WP, et al. Improved patient survival after cardiac arrest using a cardiopulmonary support system. Ann Thorac Surg 1990;49:101-5. https://doi.org/10.1016/0003-4975(90)90363-B
  13. Matsuwaka R, Sakakibara T, Shintani H, et al. Emergency cardiopulmonary bypass support in patients with severe cardiogenic shock after acute myocardial infarction. Heart Vessels 1996;11:27-9. https://doi.org/10.1007/BF01744596
  14. Suarez de Lezo J, Pan M, Medina A, et al. Percutaneous cardiopulmonary support in critical patients needing coronary interventions with stents. Cathet Cardiovasc Intervent 2002;57:467-75. https://doi.org/10.1002/ccd.10340
  15. Sakamoto S, Matsubara J, Matsubara T, et al. Clinical effectsof percutaneous cardiopulmonary support in severe heart failure: early results and analysis of complications. Ann Thorac Cardiovasc Surg 2003;9:105-10.
  16. Rhee I, Kwon SU, Sung K, et al. Experience with emergency percutaneous cardiopulmonary support in in-hospital cardiac arrest or cardiogenic shock due to the ischemic heart disease. Korean J Thorac Cardiovasc Surg 2006;39:201-7.
  17. William DC, Atkin PJ, Dembisky WP, et al. Analysis of clinical trends in a program of emergent ECLS for cardiovascular collapse. ASAIO J 1997;43:65-8.
  18. Ryu KM, Kim SH, Seo PW, et al. Initial experience of the emergency bypass system (EBS) for the patients with cardiogenic shock due to an acute myocardial infarction. Korean J Thorac Cardiovasc Surg 2008;41:329-34.
  19. Vanier J, Ommen VV, Maessen J, Geskes G, Lamerichs L, Waltenberger J. Elective high-risk percutaneous interventions supports by extracorporeal life support. Am J Cardiol 2007;99:771-3. https://doi.org/10.1016/j.amjcard.2006.10.034
  20. Burkle CM, Nuttal GA, Rihal CS. Cardiopulmonary bypass support for percutaneous coronary interventions: what the anesthesiologist needs to know. J Cardiothorac Vasc Anesth 2005;19:501-4. https://doi.org/10.1053/j.jvca.2004.10.003
  21. Orime Y, Shino M, Hata H, et al. Clinical experiences of percutaneous cardiopulmonary support: its effectiveness and limit. Artif Organs 1998;22:498-501. https://doi.org/10.1046/j.1525-1594.1998.06136.x
  22. Hill JG, Bruhn PS, Cohen SE, et al. Emergent applications of cardiopulmonary support: a multiinstitutional experience. Ann Thorac Surg 1992;54:699-704. https://doi.org/10.1016/0003-4975(92)91014-Z
  23. Scholz KH, Figulla HR, Schroder T, et al. Pulmonary and left ventricular decompression by artificial pulmonary valve incompetence during percutaneous cardiopulmonary bypass support in cardiac arrest. Circulation 1995;91:2664-8. https://doi.org/10.1161/01.CIR.91.10.2664
  24. Murashita T, Eya K, Miyatake T, et al. Outcome of the perioperative use of percutaneous cardiopulmonary support for adult cardiac surgery: factors affecting hospital mortality. Artif Organs 2004;28:189-95. https://doi.org/10.1111/j.1525-1594.2003.47255.x
  25. Alpard SK, Zwischenberger JB. Extracorporeal membrane oxygenation for severe respiratory failure. Chest Surg Clin N Am 2002;12:355-78. https://doi.org/10.1016/S1052-3359(02)00002-9
  26. Meuers KV, Lally KP, Peek G, Zwischenberger JB. ECMO: Extracorporeal cardiopulmonary support in critical care. 3rd ed. Ann Arbor, Michigan: Extracorporeal Life Support Organization. 2005.
  27. Lee SJ, Chee HK, Hwang JJ, et al. Application of veno-venoarterial extracorporeal membrane oxygenation in multitrauma patient with ARDS. Korean J Thorac Cardiovasc Surg 2010;43:104-7. https://doi.org/10.5090/kjtcs.2010.43.1.104

Cited by

  1. Percutaneous Extracorporeal Membrane Oxygenation for Graft Dysfunction after Heart Transplantation vol.47, pp.2, 2011, https://doi.org/10.5090/kjtcs.2014.47.2.100